Literature DB >> 20881164

Candida bracarensis bloodstream infection in an immunocompromised patient.

Thomas A Warren1, Lisa McTaggart, Susan E Richardson, Sean X Zhang.   

Abstract

Candida bracarensis is a recently described Candida species which is phenotypically similar to Candida glabrata. A case of C. bracarensis bloodstream infection in a bone marrow transplant patient is described and confirms this organism as an opportunistic human pathogen. The organism can be distinguished from C. glabrata by its white color on CHROMagar and by DNA sequence analysis using D1/D2 and internal transcribed spacer (ITS) primers.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20881164      PMCID： PMC3008444          DOI： 10.1128/JCM.01447-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.

Authors:  Julia Alcoba-Flórez; Sebastián Méndez-Alvarez; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; María del Pilar Arévalo
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata.

Authors:  Alexandra Correia; Paula Sampaio; Steve James; Célia Pais
Journal:  Int J Syst Evol Microbiol       Date:  2006-01       Impact factor: 2.747

3.  Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

Authors:  H F Guiot; W E Fibbe; J W van 't Wout
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

4.  Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.

Authors:  Guizhen Luo; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

5.  Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.

Authors:  Justin A Bishop; Nancy Chase; Shelley S Magill; Cletus P Kurtzman; Mark J Fiandaca; William G Merz
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

6.  Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits.

Authors:  Justin A Bishop; Nancy Chase; Richard Lee; Cletus P Kurtzman; William G Merz
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

7.  Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.

Authors:  Andrew M Borman; Rebecca Petch; Christopher J Linton; Michael D Palmer; Paul D Bridge; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

8.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

9.  Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael Gherna; Justin A Bishop; William G Merz; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

10.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079
View more
  13 in total

1.  Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Marcelo Ortega-Riveros; Iker De-la-Pinta; Guillermo Quindós; Elena Eraso
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.

Authors:  André Moreira; Sónia Silva; Cláudia Botelho; Paula Sampaio; Célia Pais; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-07-16       Impact factor: 2.574

3.  Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.

Authors:  Sun Tee Tay; Azadeh Lotfalikhani; Negar Shafiei Sabet; Sasheela Ponnampalavanar; Sofiah Sulaiman; Shiang Ling Na; Kee Peng Ng
Journal:  Mycopathologia       Date:  2014-07-15       Impact factor: 2.574

4.  Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.

Authors:  Jianling Li; Yingying Shan; Shangrong Fan; Xiaoping Liu
Journal:  Mycopathologia       Date:  2014-08-15       Impact factor: 2.574

5.  Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.

Authors:  Soraya Morales-López; Catiana Dudiuk; Walter Vivot; Wanda Szusz; Susana B Córdoba; Guillermo Garcia-Effron
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

6.  Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.

Authors:  Soraya Eugenia Morales-López; Constanza G Taverna; María Eugenia Bosco-Borgeat; Ivana Maldonado; Walter Vivot; Wanda Szusz; Guillermo Garcia-Effron; Susana B Córdoba
Journal:  Mycopathologia       Date:  2016-09-28       Impact factor: 2.574

7.  First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.

Authors:  Rogelio de J Treviño-Rangel; José F Espinosa-Pérez; Hiram Villanueva-Lozano; Alexandra M Montoya; Angel Andrade; Alexandro Bonifaz; Gloria M González
Journal:  Folia Microbiol (Praha)       Date:  2018-02-27       Impact factor: 2.099

8.  Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts.

Authors:  Mary E Brandt; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-09

9.  Molecular identification of clinical "difficult-to-identify" microbes from sequencing 16S ribosomal DNA and internal transcribed spacer 2.

Authors:  Cancan Cheng; Jingjing Sun; Fen Zheng; Kuihai Wu; Yongyu Rui
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-03       Impact factor: 3.944

10.  Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.

Authors:  Marianna Małek; Paulina Mrowiec; Karolina Klesiewicz; Iwona Skiba-Kurek; Adrian Szczepański; Joanna Białecka; Iwona Żak; Bożena Bogusz; Jolanta Kędzierska; Alicja Budak; Elżbieta Karczewska
Journal:  Folia Microbiol (Praha)       Date:  2018-10-25       Impact factor: 2.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.